BioCentury
ARTICLE | Company News

Bend Research Inc., Eli Lilly deal

February 13, 2012 8:00 AM UTC

Bend Research granted Eli Lilly a non-exclusive, worldwide license to use Bend's spray-dried dispersion (SDD) technology and other drug delivery technologies. The SDD technology improves the bioavailability of compounds with low aqueous solubility. Details were not disclosed. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article